Management of complications related to intraduodenal infusion of levodopa/carbidopa in patients with Parkinson's disease

被引：4
作者：
Santos-Garcia, Diego [1 ]
de Deus, Teresa [1 ]
Lopez-Pazos, Elina [1 ]
Macias-Arribi, Mercedes [1 ]
Llaneza-Gonzalez, Miguel A. [1 ]
Echarri-Piudo, Ana [2 ]
Carpintero, Pedro [2 ]
de la Fuente-Fernandez, Raul [1 ]
机构：
[1] Complexo Hosp Univ Ferrol, Hosp Arquitecto Marcide, Secc Neurol, Ferrol, A Coruna, Spain
[2] Complexo Hosp Univ Ferrol, Hosp Arquitecto Marcide, Secc Digest, Ferrol, A Coruna, Spain
来源：
REVISTA DE NEUROLOGIA | 2014年 / 58卷 / 11期
关键词：
Complications; Granuloma; Intraduodenal continuous levodopa/carbidopa infusion; Levodopa; Parkinson's disease; Percutaneous endoscopic gastrostomy; DUODENAL LEVODOPA INFUSION; CARBIDOPA INTESTINAL GEL; PERIPHERAL NEUROPATHY; DUODOPA; THERAPY; IMPROVEMENT; EXPOSURE; EFFICACY;
D O I：
10.33588/rn.5811.2014067
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Continuous infusion of intraduodenal levodopa/carbidopa is an effective treatment that improves the motor complications and the quality of life of patients in the advanced stages of Parkinson's disease. However, it is not free of complications. These may present in the post-operative period following surgery (gastrostomy) or in the long-term during the follow-up period and can be related with the medication (levodopa/carbidopa), the stoma, the gastrostomy or the device (pump, enteral tube, parts of the FREKA system). The aim of this review is to report on the management of the complications that can be observed in patients with advanced Parkinson's disease treated with continuous infusion of intraduodenal levodopa/carbidopa.
引用
收藏
页码：505 / 515
页数：11
相关论文
共 50 条
[21]   Outcome prediction of enteral levodopa/carbidopa infusion in advanced Parkinson's disease [J].
Westin, J. ;
Nyholm, D. ;
Groth, T. ;
Dougherty, M. S. ;
Yerramsetty, P. K. ;
Palhagen, S. E. .
PARKINSONISM & RELATED DISORDERS, 2006, 12 (08) :509-513
[22]   Levodopa–carbidopa intrajejunal infusion in Parkinson’s disease: untangling the role of age [J].
Francesca Morgante ;
Valentina Oppo ;
Margherita Fabbri ;
Enrica Olivola ;
Chiara Sorbera ;
Rosa De Micco ;
Giovanna Chiara Ielo ;
Fabiana Colucci ;
Salvatore Bonvegna ;
Alessio Novelli ;
Nicola Modugno ;
Mariachiara Sensi ;
Maurizio Zibetti ;
Leonardo Lopiano ;
Alessandro Tessitore ;
Manuela Pilleri ;
Roberto Cilia ;
Antonio E. Elia ;
Roberto Eleopra ;
Lucia Ricciardi ;
Giovanni Cossu .
Journal of Neurology, 2021, 268 :1728-1737
[23]   Levodopa-Entacapone-Carbidopa Intrajejunal Infusion in Advanced Parkinson's Disease - Interim Analysis of the ELEGANCE Study [J].
Weiss, Daniel ;
Jost, Wolfgang H. ;
Szasz, Jozsef Attila ;
Pirtosek, Zvezdan ;
Milanov, Ivan ;
Tomantschger, Volker ;
Kovacs, Norbert ;
Staines, Harry ;
Amlani, Bharat ;
Smith, Niall ;
van Laar, Teus .
MOVEMENT DISORDERS CLINICAL PRACTICE, 2025,
[24]   Levodopa dose maintenance or reduction in patients with Parkinson's disease transitioning to levodopa/carbidopa/entacapone [J].
Park, Jongkyu ;
Kim, Younsoo ;
Youn, Jinyoung ;
Lee, Phil H. ;
Sohn, Young H. ;
Koh, Seoung B. ;
Lee, Jee-Young ;
Baik, Jong S. ;
Cho, Jin W. .
NEUROLOGY INDIA, 2017, 65 (04) :746-751
[25]   Pharmacokinetics of levodopa/benserazide versus levodopa/carbidopa in healthy subjects and patients with Parkinson's disease [J].
Iwaki, Hirotaka ;
Nishikawa, Noriko ;
Nagai, Masahiro ;
Tsujii, Tomoaki ;
Yabe, Hayato ;
Kubo, Madoka ;
Ieiri, Ichiro ;
Nomoto, Masahiro .
NEUROLOGY AND CLINICAL NEUROSCIENCE, 2015, 3 (02) :68-73
[26]   Complications of levodopa therapy in Parkinson's disease [J].
Dubow, Jordan ;
Olanow, C. Warren .
EXPERT OPINION ON ORPHAN DRUGS, 2019, 7 (09) :391-397
[27]   Levodopa/Carbidopa Enteral Suspension: A Review in Advanced Parkinson's Disease [J].
Hoy, Sheridan M. .
DRUGS, 2019, 79 (15) :1709-1718
[28]   Gastroretentive Carbidopa/Levodopa, DM-1992, for the Treatment of Advanced Parkinson's Disease [J].
Metman, Leo Verhagen ;
Stover, Natividad ;
Chen, Cuiping ;
Cowles, Verne E. ;
Sweeney, Michael .
MOVEMENT DISORDERS, 2015, 30 (09) :1222-1228
[29]   Levodopa–Carbidopa Intestinal Gel in Patients with Parkinson’s Disease: A Systematic Review [J].
Karin Wirdefeldt ;
Per Odin ;
Dag Nyholm .
CNS Drugs, 2016, 30 :381-404
[30]   Continuous intestinal infusion of levodopa-carbidopa in patients with advanced Parkinson's disease in Spain: Subanalysis by autonomous community [J].
Santos-Garcia, D. ;
Catalan, M. J. ;
Puente, V ;
Valldeoriola, F. ;
Regidor, I ;
Mir, P. ;
Matias-Arbelo, J. ;
Parra, J. C. ;
Grandas, F. .
NEUROLOGIA, 2021, 36 (02) :101-111
12345